Market Closed -
Other stock markets
|
Pre-market 08:15:09 | |||
13.95 USD | -0.78% | 14.91 | +6.88% |
01:19pm | Teva Pharm Q1 profit falls short of estimates, revenue gains | RE |
04-30 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.62% | 15.8B | |
+33.43% | 700B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.98% | 236B | |
+6.80% | 202B | |
-9.24% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing